"EQUIP-A-Pharma is about point-of-need manufacturing—hospitals, military bases, disaster zones—ensuring rapid drug ...

The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs.

The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.

The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...

Eli Lilly and Company (LLY) announced on Wednesday that the U.S. Food and Drug Administration (FDA) has approved a label ...

Objective To determine the prevalence, nature and predictors of patients having medication administration omissions in hospitals. Methods All medication administration omissions data collected using ...